Clinical Trials
15 trialsNCT01660984 2026-06-05
Natural History Study of Children and Adults With Medullary Thyroid Cancer
National Institutes of Health Clinical Center (CC)
Recruiting
NCT06444880 2026-06-04
Phase II Trial of Ubamatamab Alone or in Combination With Cemiplimab in MUC16-Expressing SMARCB1-Deficient Malignancies
M.D. Anderson Cancer Center
Phase 2 Recruiting
NCT07259304 2026-05-28
Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors
University of Southern California
Recruiting
NCT06814496 2026-05-20
RABBIT
University of Arizona
Phase 1/2 Recruiting
NCT06141369 2026-04-09
Treatment of Advanced Endocrine Tumor With Iindividualized mRNA Neoantigen Vaccine (mRNA-0523-L001)
Shanghai Jiao Tong University School of Medicine
Phase NA Recruiting
NCT07142005 2026-04-02
Cultural Adaptation of an Educational Tool in Medullary Thyroid Cancer
M.D. Anderson Cancer Center
Recruiting
NCT04216732 2026-03-05
Natural History of Medullary Thyroid Cancer to Inform Advanced Disease Management
M.D. Anderson Cancer Center
Recruiting
NCT07383246 2026-02-03
CAST-MTC
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 3 Recruiting
NCT03892993 2026-01-09
Patient Decision Aid in Supporting Decision-Making About When to Start or Stop New Drugs, Join Clinical Trials, or Continue Active Surveillance in Patients With Medullary Thyroid Cancer and Their Caregivers
M.D. Anderson Cancer Center
Phase NA Recruiting
NCT07138716 2025-08-24
Research on the Application of 68Ga-DOTA-CCK-FS PET/CT in MTC
Peking Union Medical College Hospital
Phase NA Recruiting
NCT07118176 2025-08-12
Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers
Jonsson Comprehensive Cancer Center
Phase 1 Recruiting
NCT06523582 2024-07-26
Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients
Universidad Nacional Autonoma de Mexico
Recruiting
NCT06520319 2024-07-25
Head-to-head Study of 68Ga-MGS5 Versus 68Ga-DOTATATE PET/CT in Patients With Medullary Thyroid Carcinoma
First Affiliated Hospital of Fujian Medical University
Phase 1 Recruiting
NCT06277180 2024-02-26
68Ga-TCR-FAPI PET/CT Guided Precision Surgery for MTC
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase NA Recruiting
NCT05830500 2023-07-25
Study of Anlotinib in Patients With Advanced Medullary Thyroid Carcinoma
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 4 Recruiting